Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 7: 41572, 2017 02 02.
Article in English | MEDLINE | ID: mdl-28148966

ABSTRACT

Endoplasmic reticulum (ER) stress is implicated in chronic kidney disease (CKD) development in patients and in animal models. Here we show that ER stress inhibition through 4-phenylbutyric acid (4-PBA) administration decreases blood pressure, albuminuria, and tubular casts in an angiotensin II/deoxycorticosterone acetate/salt murine model of CKD. Lower albuminuria in 4-PBA-treated mice was associated with higher levels of cubilin protein in renal tissue membrane fractions. 4-PBA decreased renal interstitial fibrosis, renal CD3+ T-cell and macrophage infiltration, mRNA expression of TGFß1, Wnt signaling molecules, and ER stress-induced pro-inflammatory genes. CHOP deficient mice that underwent this model of CKD developed hypertension comparable to wild type mice, but had less albuminuria and tubular casts. CHOP deficiency resulted in higher nephrin levels and decreased glomerulosclerosis compared to wild type mice; this effect was accompanied by lower macrophage infiltration and fibrosis. Our findings portray ER stress inhibition as a means to alleviate hypertensive CKD by preserving glomerular barrier integrity and tubular function. These results demonstrate ER stress modulation as a novel target for preserving renal function in hypertensive CKD.


Subject(s)
Endoplasmic Reticulum Stress/drug effects , Hypertension/etiology , Hypertension/metabolism , Proteinuria/etiology , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/metabolism , Angiotensin II/metabolism , Animals , Apoptosis/genetics , Biopsy , Blood Pressure/drug effects , Disease Models, Animal , Fibrosis , Gene Expression Profiling , Humans , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Male , Mice , Mice, Knockout , Nephrosclerosis/etiology , Nephrosclerosis/metabolism , Nephrosclerosis/pathology , Phenylbutyrates/pharmacology , Proteinuria/drug therapy , Renal Insufficiency, Chronic/drug therapy , Renal Insufficiency, Chronic/pathology , Transcription Factor CHOP/deficiency , Transcriptome , Urinalysis
2.
J Histochem Cytochem ; 63(1): 32-44, 2015 01.
Article in English | MEDLINE | ID: mdl-25319549

ABSTRACT

Schimke immuno-osseous dysplasia (SIOD) is a pleiotropic disorder caused by mutations in the SWI/SNF2-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like-1 (SMARCAL1) gene, with multiple clinical features, notably end-stage renal disease. Here we characterize the renal pathology in SIOD patients. Our analysis of SIOD patient renal biopsies demonstrates the tip and collapsing variants of focal segmental glomerulosclerosis (FSGS). Additionally, electron microscopy revealed numerous glomerular abnormalities most notably in the podocyte and Bowman's capsule. To better understand the role of SMARCAL1 in the pathogenesis of FSGS, we defined SMARCAL1 expression in the developing and mature kidney. In the developing fetal kidney, SMARCAL1 is expressed in the ureteric epithelium, stroma, metanephric mesenchyme, and in all stages of the developing nephron, including the maturing glomerulus. In postnatal kidneys, SMARCAL1 expression is localized to epithelial tubules of the nephron, collecting ducts, and glomerulus (podocytes and endothelial cells). Interestingly, not all cells within the same lineage expressed SMARCAL1. In renal biopsies from SIOD patients, TUNEL analysis detected marked increases in DNA fragmentation. Our results highlight the cells that may contribute to the renal pathogenesis in SIOD. Further, we suggest that disruptions in genomic integrity during fetal kidney development contribute to the pathogenesis of FSGS in SIOD patients.


Subject(s)
Arteriosclerosis/metabolism , Arteriosclerosis/pathology , DNA Helicases/metabolism , Gene Expression Regulation , Immunologic Deficiency Syndromes/metabolism , Immunologic Deficiency Syndromes/pathology , Kidney/metabolism , Kidney/pathology , Nephrotic Syndrome/metabolism , Nephrotic Syndrome/pathology , Osteochondrodysplasias/metabolism , Osteochondrodysplasias/pathology , Pulmonary Embolism/metabolism , Pulmonary Embolism/pathology , Animals , Arteriosclerosis/complications , Arteriosclerosis/genetics , Child , Child, Preschool , DNA Fragmentation , Female , Glomerulosclerosis, Focal Segmental/complications , Humans , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/genetics , Kidney/embryology , Kidney/ultrastructure , Male , Mice , Nephrotic Syndrome/complications , Nephrotic Syndrome/genetics , Osteochondrodysplasias/complications , Osteochondrodysplasias/genetics , Primary Immunodeficiency Diseases , Pulmonary Embolism/complications , Pulmonary Embolism/genetics
3.
Am J Kidney Dis ; 62(1): 135-8, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23602193

ABSTRACT

Kidney injury from mercury is known to cause dose-related tubular dysfunction and idiosyncratic nephrotic syndrome according to various case reports. Motivated by a patient with subacute-onset nephrotic syndrome, histologic features of secondary focal segmental glomerulosclerosis, and concurrent mercury toxicity, we conducted a systematic review to explore renal histologic changes in patients with toxic mercury exposures and nephrotic syndrome. Data were extracted from a patient's clinical record. MEDLINE/Ovid was searched from 1950 to November 2010 using a prespecified search strategy. Two nephrology textbooks and the UpToDate online database also were searched. Inclusion criteria were studies of humans with nephrotic syndrome, nephrotic-range proteinuria, or kidney biopsy results reported. There were no exclusion criteria. We identified 27 other reports of 42 patients with nephrotic syndrome or nephrotic-range proteinuria. Of the 26 individuals, including our patient, who underwent kidney biopsy, histology showed glomerular disease in 21. Of these 20 biopsies, 4 showed minimal change disease and 15 showed membranous glomerulonephritis. Mercury exposure can lead to various glomerular lesions; we emphasize the importance of a careful occupational and dietary history in elucidating a cause for the undetermined nephrotic syndrome.


Subject(s)
Mercury/urine , Nephrotic Syndrome/diagnosis , Nephrotic Syndrome/urine , Animals , Environmental Exposure/adverse effects , Fishes , Fresh Water , Humans , Male , Mercury/administration & dosage , Middle Aged
4.
Am J Respir Cell Mol Biol ; 44(2): 213-21, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20395634

ABSTRACT

Despite the emerging use of bronchial thermoplasty in asthma therapy, the response of airway smooth muscle (ASM) to extreme temperatures is unknown. We investigated the immediate effects of exposing ASM to supraphysiologic temperatures. Isometric contractions were studied in bovine ASM before and after exposure to various thermal loads and/or pharmacologic interventions. Actin-myosin interactions were investigated using a standard in vitro motility assay. We found steep thermal sensitivity for isometric contractions evoked by acetylcholine, with threshold and complete inhibition at less than 50°C and greater than 55°C, respectively. Contractile responses to serotonin or KCl were similarly affected, whereas isometric relaxations evoked by the nitric oxide donor S-nitrosyl-N-acetylpenicillamine or the ß-agonist isoproterenol were unaffected. This thermal sensitivity developed within 15 minutes, but did not evolve further over the course of several days (such a rapid time-course rules out heat shock proteins, apoptosis, autophagy, and necrosis). Although heat-sensitive transient receptor potential (TRPV2) channels and the calmodulin-dependent (Cam) kinase-II-induced inactivation of myosin light chain kinase are both acutely thermally sensitive, with a temperature producing half-maximal effect (T(1/2)) of 52.5°C, the phenomenon we describe was not prevented by blockers of TRPV2 channels (e.g., ruthenium red, gadolinium, zero-Ca(2+) or zero-Na(+)/zero-Ca(2+) media, and cromakalim) or of Cam kinase-II (e.g., W7, trifluoperazine, and KN-93). However, direct measurements of actin-myosin interactions showed the same steep thermal profile. The functional changes preceded any histologic evidence of necrosis or apoptosis. We conclude that extreme temperatures (such as those used in bronchial thermoplasty) directly disrupt actin-myosin interactions, likely through a denaturation of the motor protein, leading to an immediate loss of ASM cell function.


Subject(s)
Actins/metabolism , Hot Temperature/adverse effects , Muscle, Smooth/physiology , Myosins/metabolism , Trachea/physiology , Acetylcholine/pharmacology , Animals , Bronchi/drug effects , Bronchi/physiology , Cattle , In Vitro Techniques , Isometric Contraction/drug effects , Isometric Contraction/physiology , Isoproterenol/pharmacology , Muscle, Smooth/drug effects , Myosin-Light-Chain Kinase/metabolism , Protein Denaturation , TRPV Cation Channels/metabolism , Trachea/drug effects , Trachea/injuries , Trachea/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...